Does TIRAGOLUMAB Cause Off label use? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Off label use have been filed in association with TIRAGOLUMAB. This represents 10.4% of all adverse event reports for TIRAGOLUMAB.
58
Reports of Off label use with TIRAGOLUMAB
10.4%
of all TIRAGOLUMAB reports
10
Deaths
15
Hospitalizations
How Dangerous Is Off label use From TIRAGOLUMAB?
Of the 58 reports, 10 (17.2%) resulted in death, 15 (25.9%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRAGOLUMAB. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does TIRAGOLUMAB Cause?
Hyperthyroidism (39)
Pneumonia (29)
Pneumonitis (26)
Infusion related reaction (23)
Intentional product use issue (23)
Death (21)
Adrenal insufficiency (20)
Troponin increased (20)
Colitis (15)
Febrile neutropenia (14)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TIRAGOLUMAB Alternatives Have Lower Off label use Risk?
TIRAGOLUMAB vs TIRBANIBULIN
TIRAGOLUMAB vs TIRZEPATIDE
TIRAGOLUMAB vs TISLELIZUMAB
TIRAGOLUMAB vs TISOTUMAB VEDOTIN
TIRAGOLUMAB vs TISOTUMAB VEDOTIN-TFTV